ZA200703793B - Defective influenza virus particles - Google Patents

Defective influenza virus particles

Info

Publication number
ZA200703793B
ZA200703793B ZA200703793A ZA200703793A ZA200703793B ZA 200703793 B ZA200703793 B ZA 200703793B ZA 200703793 A ZA200703793 A ZA 200703793A ZA 200703793 A ZA200703793 A ZA 200703793A ZA 200703793 B ZA200703793 B ZA 200703793B
Authority
ZA
South Africa
Prior art keywords
influenza virus
virus particles
defective influenza
defective
particles
Prior art date
Application number
ZA200703793A
Inventor
De Wit Emmie
Ron A M Fouchier
Monique I J Spronken
Albert D M E Osterhaus
Original Assignee
Solvay Pharm Bv
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv, Univ Erasmus Medical Ct filed Critical Solvay Pharm Bv
Publication of ZA200703793B publication Critical patent/ZA200703793B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200703793A 2004-11-11 2007-05-10 Defective influenza virus particles ZA200703793B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105696 2004-11-11

Publications (1)

Publication Number Publication Date
ZA200703793B true ZA200703793B (en) 2008-10-29

Family

ID=34929842

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703793A ZA200703793B (en) 2004-11-11 2007-05-10 Defective influenza virus particles

Country Status (3)

Country Link
CN (1) CN101056976A (en)
RU (1) RU2420577C2 (en)
ZA (1) ZA200703793B (en)

Also Published As

Publication number Publication date
RU2420577C2 (en) 2011-06-10
CN101056976A (en) 2007-10-17
RU2007121740A (en) 2008-12-20

Similar Documents

Publication Publication Date Title
IL182817A0 (en) Defective influenza virus particles
SG2014012868A (en) Functional influenza virus like particles (vlps)
EP1888459A4 (en) Silicon nanosponge particles
SG113519A1 (en) Sorting particles
ZA200800505B (en) Modified influenza virus for monitoring and improving vaccine efficiency
EP1973837A4 (en) Nanolipidic particles
ZA200705145B (en) Rescue of influenza virus
ATE480322T1 (en) CERAMIC PARTICLES
HK1223968A1 (en) Rabies virus and compositions and methods thereof
IL183018A0 (en) Staibilized individually coated ramipril particles, compositions and methods
SI1942933T1 (en) Canine influenza vaccines
GB0523347D0 (en) Influenza a virus detection method and kit therefor
EP1871786A4 (en) Peptide vaccine for influenza virus
GB0416487D0 (en) Modified virus
DE602005014972D1 (en) PARTICLE
EP1907537A4 (en) Paramyxoviridae virus preparations
GB2420544B (en) Fall arrest support
GB0610209D0 (en) Assay particles
GB0401846D0 (en) Novel particles
GB0518478D0 (en) Particles
GB2437799B (en) Defective interfering virus
ZA200703793B (en) Defective influenza virus particles
EP1868577A4 (en) Lacidipine particles
GB0714951D0 (en) Fall arrest support
GB0403262D0 (en) Particles